Prediagnostic expressions in health records predict mortality in Parkinson's disease: A proof-of-concept study

被引:3
|
作者
Kuusimaki, Tomi [1 ,2 ]
Sainio, Jani [3 ,4 ]
Kurki, Samu [3 ,4 ]
Vahlberg, Tero [5 ]
Kaasinen, Valtteri [1 ,2 ]
机构
[1] Univ Turku, Clin Neurosci, Turku, Finland
[2] Turku Univ Hosp, Neuroctr, Hameentie 11,POB 52, FIN-20521 Turku, Finland
[3] Univ Turku, Auria Biobank, Turku, Finland
[4] Turku Univ Hosp, Turku, Finland
[5] Univ Turku, Dept Biostat, Turku, Finland
关键词
Parkinson 's disease; Prodromal; Data mining; Electronical health records; Mortality; Prognosis; MOTOR; RISK; ASSOCIATION; DEPRESSION; SURVIVAL; FEATURES; CRITERIA;
D O I
10.1016/j.parkreldis.2021.12.015
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The relationship of prodromal markers of PD with PD mortality is unclear. Electronic health records (EHRs) provide a large source of raw data that could be useful in the identification of novel relevant prognostic factors in PD. We aimed to provide a proof of concept for automated data mining and pattern recognition of EHRs of PD patients and to study associations between prodromal markers and PD mortality. Methods: Data from EHRs of PD patients (n = 2522) were collected from the Turku University Hospital database between 2006 and 2016. The data contained >27 million words/numbers and >750000 unique expressions. The 5000 most common words were identified in three-year time period before PD diagnosis. Cox regression was used to investigate the association of expressions with the 5-year survival of PD patients. Results: During the five-year period after PD diagnosis, 839 patients died (33.3%). If expressions associated with psychosis/hallucinations were identified within 3 years before the diagnosis, worse survival was observed (hazard ratio = 1.71, 95%CI = 1.46-1.99, p < 0.001). Similar effects were observed for words associated with cognition (1.23, 1.05-1.43, p = 0.009), constipation (1.34, 1.15-1.56, p = 0.0002) and pain (1.34, 1.12-1.60, p = 0.001). Conclusions: Automated mining of EHRs can predict relevant clinical outcomes in PD. The approach can identify factors that have previously been associated with survival and detect novel associations, as observed in the link between poor survival and prediagnostic pain. The significance of early pain in PD prognosis should be the focus of future studies with alternate methods.
引用
收藏
页码:35 / 39
页数:5
相关论文
共 50 条
  • [31] Could lung bacterial dysbiosis predict ICU mortality in patients with extra-pulmonary sepsis? A proof-of-concept study
    Guillen-Guio, Beatriz
    Hernandez-Beeftink, Tamara
    Ciuffreda, Laura
    Rodriguez-Perez, Hector
    Corrales, Almudena
    Flores, Carlos
    Villar, Jesus
    Dominguez, David
    Viera Camacho, David
    Noemi Gonzalez, Gabriela
    Espinosa, Elena
    Baez-Ortega, Adrian
    Corrales, Almudena
    Villar, Jesus
    Flores, Carlos
    Soro, Marina
    Alcoba-Florez, Julia
    Gonzalez-Montelongo, Rafaela
    INTENSIVE CARE MEDICINE, 2020, 46 (11) : 2118 - 2120
  • [32] Motor symptom machine rating system for complete MDS-UPDRS III in Parkinson’s disease: A proof-of-concept pilot study
    Zhu Xue
    Chen Zhonglue
    Ling Yun
    Luo Ningdi
    Yin Qianyi
    Zhang Yichi
    Zhao Aonan
    Ye Guanyu
    Zhou Haiyan
    Pan Jing
    Zhou Liche
    Cao Linghao
    Huang Pei
    Zhang Pingchen
    Chen Cheng
    Shi Weikun
    Lin Shinuan
    Zhuang Haimei
    Zhao Jin
    Ren Kang
    Tan Yuyan
    Liu Jun
    中华医学杂志英文版, 2024, 137 (13)
  • [33] Patient-Derived Enteroids and Colonoids for Measuring Enteroendocrine Function in Response to Luminal Contents: A Proof-of-Concept Study in Parkinson's Disease
    Manfready, Richard A.
    Shaikh, Maliha W.
    Zhang, Lijuan
    Lawrence, Kristi M.
    Voigt, Robin M.
    Forsyth, Christopher B.
    Goetz, Christopher G.
    Keshavarzian, Ali
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S108 - S108
  • [34] Motor symptom machine rating system for complete MDS-UPDRS III in Parkinson's disease: A proof-of-concept pilot study
    Zhu, Xue
    Chen, Zhonglue
    Ling, Yun
    Luo, Ningdi
    Yin, Qianyi
    Zhang, Yichi
    Zhao, Aonan
    Ye, Guanyu
    Zhou, Haiyan
    Pan, Jing
    Zhou, Liche
    Cao, Linghao
    Huang, Pei
    Zhang, Pingchen
    Chen, Cheng
    Shi, Weikun
    Lin, Shinuan
    Zhuang, Haimei
    Zhao, Jin
    Ren, Kang
    Tan, Yuyan
    Liu, Jun
    CHINESE MEDICAL JOURNAL, 2024, 137 (13) : 1632 - 1634
  • [35] Blockchain for Increased Trust in Virtual Health Care: Proof-of-Concept Study
    Hasselgren, Anton
    Rensaa, Jens-Andreas Hanssen
    Kralevska, Katina
    Gligoroski, Danilo
    Faxvaag, Arild
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2021, 23 (07)
  • [36] Analysing clinical text from electronic health records to diagnose anti-NMDAR encephalitis, a proof-of-concept study
    Arino, H.
    Stewart, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 98 - 98
  • [37] Functional imaging of hippocampal dysfunction among persons with Alzheimer's disease: a proof-of-concept study
    Arciniegas, David B.
    Tregellas, Jason R.
    Rojas, Donald C.
    Hewitt, Burlleen
    Anderson, C. Alan
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 779 - 783
  • [38] Proof-of-concept clinical trial on the use of oral ridaforolimus, an investigational mTOR inhibitor, for enhanced autophagy in Parkinson's disease
    Machado, D. G.
    Jabbari, B.
    MOVEMENT DISORDERS, 2010, 25 (07) : S300 - S300
  • [39] SOLRIAMFETOL TREATMENT OF EXCESSIVE DAYTIME SLEEPINESS IN PARKINSON'S DISEASE: RESULTS FROM A PHASE 2 PROOF-OF-CONCEPT TRIAL
    Schweitzer, Paula K.
    Hauser, Robert A.
    Amara, Amy W.
    Videnovic, Aleksandar
    Comella, Cynthia
    Liu, Kris
    Sterkel, Amanda L.
    Gottwald, Mildred D.
    Steinerman, Joshua R.
    Jochelson, Philip
    Emsellem, Helene
    SLEEP, 2019, 42
  • [40] A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson's disease
    Rascol, Olivier
    Ferreira, Joaquim
    Negre-Pages, Laurence
    Perez-Lloret, Santiago
    Lacomblez, Lucette
    Galitzky, Monique
    Lemarie, Jean-Christophe
    Corvol, Jean-Christophe
    Brotchie, Jonathan M.
    Bossi, Laura
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 (04) : 557 - 564